4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:常规产品包括:丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1927-02
商品详细Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1927-02
Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1927-02
Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1927-02
商品编号: 10-1927-02
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Applications & Benefits

Abasic II Phosphoramidite

Abasic II Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-1927-02Abasic II Phosphoramidite0.25g£380.00£361.00Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1927-90Abasic II Phosphoramidite100µmoles£120.00£114.00Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1927-95Abasic II Phosphoramidite50µmoles£64.00£60.80Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

Abasic II Phosphoramidite

Abasic II Phosphoramidite

Glen Research

Abasic II Phosphoramidite

Structure

Catalog Number: 10-1927-xx

Description: Abasic II Phosphoramidite

5-O-Dimethoxytrityl-1-O-tert-butyldimethylsilyl-2-deoxyribose-3-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C41H59N2O7PSiM.W.: 750.98F.W.: 196.1

Diluent: Anhydrous AcetonitrileAdd fresh diluent to product vial to recommended concentration and swirl vial occasionally over several minutes until product is completely dissolved.(Some oils may require between 5 and 10 minutes.) Use care to maintain anhydrous conditions.In case of transfer to alternate vial type, ensure recipient vial has been pre-dried. For more information, see http://www.glenres.com/Technical/TB_ABITransfer.pdf.
Coupling: 6 minute coupling time recommended.
Deprotection: Synthesize using acetyl-protected dC and deprotect in 30% Ammonium Hydroxide/40% Methylamine 1:1 (AMA) at 65°C for 10 min OR Synthesize using dmf-dG and deprotect in EtOH/30% Ammonium Hydroxide (1:3) for 24 hrs at room temperature.To generate the abasic site, dry the oligo down and take up in 0.25mL 80% Acetic acid.After 30 min at room temperature, add 0.25mL water and let sit for an additional 4 hrs.Quench with 0.5mL 2M TEAA and desalt on a Glen Gel-Pak™ column or equivalent.Store the oligo atpH 6-7 at 4°C or frozen.Do not dry; drying results in cleavage of the abasic site.See Technical Bulletin for details (Technical Bulletin).
Storage: Freezer storage, -10 to -30°C, dry
Stability in Solution: 2-3 days

8-Amino-G is formed along with 8-oxo-G as themajor mutagenic lesions formed in DNA damage caused by 2-nitropropane.2-Nitropropane is an industrial solvent and a component of paints, dyes andvarnishes, and is also present in cigarette smoke. Thymine glycol(5,6-dihydroxy-5,6-dihydrothymine) is formed when thymine is subjected tooxidative stress, including ionizing radiation. Oxidation of the 5,6 double bondof Thymidine generates two chiral centers at C5 and C6. The cis-5R,6S form isgenerated as the predominant product along with the other diastereomer, thecis-5S,6R form. The presence of thymidine glycol in DNA has significantbiological consequences and many organisms possess specific repair enzymes forthe excision of this lesion. 2-Aminoimidazolone (Iz) and its hydrolysis productimidazolone (Z) are major oxidation products of G. Access to these two potentiallesions is not possible during oligonucleotide synthesis because they are sobase-labile. A suitable precursor, 8-methoxy-dG (8-OMe-dG), to dIz has now beendescribed. The conversion of 8-OMe-dG to dIz takes place by irradiation of theoligonucleotide (1 mM) in 50 mM sodium cacodylate buffer, pH 7, in the presenceof riboflavin (50 µM) for 2 minutes on a transilluminator (366 nm), underaerobic conditions at 4°C. Surprisingly for a photochemical reaction, theconversion is virtually quantitative.

Hydrolysis ofnucleoside residues in DNA occurs to generate abasic sites. Most commonly, dAsites are hydrolyzed causing depurination and leading to abasic residues. Forresearchers trying to determine if their source of depurination in chemicalsynthesis of DNA is reagent, fluidics or protocol-based, we offer adepurination-resistant dA monomer. A new chemical method allows the generationof abasic sites in double and single stranded oligonucleotides using very mildspecific conditions and with very low probability of side reactions. Theoriginal Abasic Phosphoramidite (10-1924) has been discontinued since itexhibits low coupling efficiency and the post-synthesis chemistry is fairlychallenging. Abasic II Phosphoramidite1 is the replacement for the preparationof a true abasic site. This product has the advantage of simplicity in that thesilyl group is removed post-synthesis using aqueous acetic acid. dSpacer hasalso been used successfully as a mimic of the highly base-labile abasic site.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Abasic II Phosphoramidite

Abasic II Phosphoramidite

Glen Research

MSDS

Glen Report 21.1: TECHNICAL BRIEF - PREPARATION OF OLIGONUCLEOTIDES CONTAINING ABASIC SITES

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Abasic II Phosphoramidite

Abasic II Phosphoramidite

Glen Research

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1927-9550µmoles.038grams.53.3321.25.91.67.17
10-1927-90100µmoles.075grams120127.55.4541
10-1927-020.25grams.25grams3.3397.6758.636.6326.6419.534.88
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1927-9550µmoles.038grams.75.078.65.383.91.54
10-1927-90100µmoles.075grams1.5.0723.614.7510.731.48
10-1927-020.25grams.25grams4.97.079358.1342.275.81
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-1927-9550µmoles.038grams.75.0710.26.384.64
10-1927-90100µmoles.075grams1.5.0725.215.7511.45
10-1927-020.25grams.25grams4.97.0794.659.1343

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

品牌介绍
Athens Research & Technology—供应多款蛋白、酶制品 Athens Research & Technology是成立于2010年的新兴生物高科技制品公司,该公司拥有BSL-2实验室及超过11000平方英尺的cGMP生产厂房,并且通过ISO 9001:2008认证。Athens公司致力于纯化分离高纯度,高活性的人类蛋白质及研发多克隆抗血清产品。提供包括高纯度及活性的丝氨酸蛋白酶,蛋白酶抑制剂,中性粒细胞酶,载脂蛋白,脂蛋白,血小板蛋白,转铁蛋白,免疫球蛋白等等。公司产品适用于炎症,冠状动脉疾病,自身免疫性疾病,癌症,阿尔茨海默氏病等众多研究领域,已被世界*制药公司及诊断试剂公司用于体外诊断试剂盒/免疫检测试剂盒、药物筛选、细胞培养液(包括干细胞)等产品研发。除了人类蛋白质,我们还从动物血清和组织中分离多种蛋白质及酶类。此外,Athens Research and Technology还提供特殊试剂/蛋白定制服务,以满足研究人员的不同需求。